Overall, further clinical trials in humans are necessary to demonstrate that dietary interventions can simultaneously influence the microbiome, intestinal permeability, inflammation, and neurocognitive symptoms, making them a compelling complementary strategy in the treatment of ME/CFS [10, 11, 13]
How PlexusDx Supports a More Personalized Approach PlexusDx emphasizes that insurance coverage decisions and genetic predisposition information work together to support personalized GLP-1 treatment planning
DOI: 10.1155/2013/767482 Empting LD
10.1017/S0029665199000580 38 SelhubJ.MorrisM
Heres a quick recap of a few key distinctions between the drugs
Some patients prefer an in-clinic environment because it feels more structured, more private, or easier to separate from the rest of the day